Psyence Biomedical Ltd. (PBMWW) stock
PBMWWNasdaqPharmaceutical PreparationsFiscal year ends March 31Also trades as PBM
$0.01−0.00 (-2.50%)
Close on Oct 30, 2026Market cap –P/E –Yield –
Psyence Biomedical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
No revenue figures for Psyence Biomedical
Psyence Biomedical has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.